Priya Abani
CEO
AliveCor Inc.
Scott Alderucci
Director, Process Development Science
Curia Global
Virginia Amann
Founder
ENTENTE Network
Gbola Amusa
Partner, Chief Scientific Officer
Chardan
Jim Anthony
President
Parexel Biotech
Alex Aravanis
Moonwalk Biosciences
Anna Barry
Venture Partner
Deerfield
Chris Benko
Koneksa
Shirley Bergin
Consultant, Advisor & Board Member, Former COO / Executive Producer
TEDMED
Irene Blat
Senior Director, Search and Evaluation for Oncology
Servier Pharmaceuticals
Adam Bluestein
Contributing Writer
Fast Company
Raysa Bousleiman
Senior VP, Life Science & Healthcare Venture Capital Relationships
Silicon Valley Bank
Paul Bresge
Ray Therapeutics
Rick Bright
CEO/Founder, Bright Global Health
Former BARDA Director
Steve Brozak
WBB Securities LLC
Stephen Bruso
Investor
Morning Side Ventures
Jay Campbell
Managing Director, Clinical Accelerator and Venture Fund
Cancer Research Institute
Gabe Cavazos
Senior Managing Director, Investment Banking, Biopharma
Leerink Partners
Akshay Chellappa
Director, Corporate Development
Gilead
Julie Chen
Chief Medical Officer
Human Longevity
Colin Davies
VP, Data Science
TRIPP
Cris De Luca
Partner, Digital
Sanofi Ventures
Allison DeAngelis
Biotech Reporter
STAT News
Daniel Dornbusch
Excision BioTherapeutics
David Ewing Duncan
Journalist
Author & Researcher
Mark Edwards
CEO & Co-founder
ViewMind
Julie Everett
Chief Business Officer
Eidos Therapeutics Inc., a BridgeBio Company
Stacy Feld
Regional Head, West North America
Johnson & Johnson Innovation
G. Alexander Fleming
Co-Founder & CEO
Kinexum
Cameron Gardner
Director, Research Development
JURA Bio
Andrei Georgescu
Vivodyne
Chris Ghadban
Chief of Staff
Alix Ventures
Jennifer Goldsack
Digital Medicine Society (DiMe)
Walter Greenleaf
Visiting Scholar
Stanford Virtual Human Interaction Lab
Kimberly Ha
CEO and Founder
KKH Advisors
Shelley Hartman
Aegle Therapeutics Corporation
Jim Healy
Managing Partner
Sofinnova Investments
Guy Heathers
Co-Founder & Chief Business Officer
Albatroz Therapeutics
Abraham Heifets
CEO and Co-Founder
Atomwise
Erin Hertzog
Partner
Foley Hoag
Sarah Hill
CEO & Chief Storyteller
Healium
William Ho
Founder, President & CEO
IN8bio
Beth Hoffman
Origami Therapeutics
Christian Howell
Chief Commercial Officer
Cognito Therapeutics
Tim Hunt
Alliance for Regenerative Medicine
Stacy Hurt
Patient
..
Nouhad Husseini
SVP, Head of Business Development and Corporate Strategy
Regeneron
Rachelle Jacques
President and CEO
Akari Therapeutics
Ben Johnson
Managing Director, National Head of Early Stage
Marc Jones
Altoida
Maha Katabi
General Partner
Nikole Kimes
Founder & CEO
Siolta Therapeutics
Tarcan Kiper
Neo Auvra Corp.
Susan Kirsh
Deputy Undersecretary for Health - Discovery, Education and Affiliate Networks
US Department of Veterans Affairs
Ekaterine Kortkhonjia
Senior Director, Early Innovation Partnering
JnJ Innovation
Mark Kotter
Scientific Founder
clock.bio
Daniel Kraft
Founder & Chair
NextMed Health
Christian Kramme
Chief Scientific Officer
Gameto
Samarth Kulkarni
CRISPR
Seema Kumar
Cure
Kyle LaHucik
Senior Reporter
Endpoints News
Andrew Lam
Principal, Special Investments
Ally Bridge Group
Vivian Lee
Managing Director
Aqua Partners LLC
Christine Lemke
Co-Founder and Chief Executive Officer
Evidation Health
Ron Leuty
San Francisco Business Times
Angus Liu
Senior Staff Writer
FierceBiotech
Philippe Lopes-Fernandes
Executive VP and CBO
Ipsen
Ted Love
Chairman
Biotechnology Innovation Organization
David Maltz
Intervalent
Michael Margolis
Senior Managing Director, Co-Head of Healthcare Investment Banking
Oppenheimer & Co
Peter Marks
Director CBER
FDA
Neal Masia
EntityRisk
Scott McCarty
Life Science & Healthcare – Southeast, SVB
John McDonald
Corporate Vice President, Global Head of Business Development and M&A
Novo Nordisk
Wyatt McDonnell
Infinimmune, Inc.
Glennis Mehra
Director, BioLabs
NYU Langone
Ricky Mehra
Continuum Health Ventures
Kenneth Moch
Euclidean Life Science Advisors
Martina Molsbergen
C14 Consulting Group
Julia Moore
Breakout Ventures
Alex Morgan
Khosla Ventures
Aziz Mottiwala
CCO
Tarsus Pharmaceuticals
Matthias Müllenbeck
SVP, Head of Global Business Development & Alliance Management
Merck KGaA, Darmstadt, Germany
Michael Notaras
VP, Biotech Public Equities & Venture Capital
Decheng Capital
Crystal Nyitray
Encellin
Jack O'Meara
Ochre Bio
Daniel Oliver
Rejuvenate Bio
Tim Opler
Managing Director, Global Healthcare Group
Stifel
Tom Oxley
Synchron
Art Pappas
CEO & Managing General Partner
Pappas Capital
Neel Patel
Executive Managing Director, Head Commercial Advisory Group - Consulting
Syneos Health Consulting
Alex Philippidis
Senior Business Editor
GEN
Jo Jo Platt
Platt & Associates
Linda Pullan
Business Development Consultant
Pullan Consulting
Marco Quarta
Rubedo Life Sciences
John Ramunas
Rejuvenation Technologies
Nina Rawal
Partner and Co-Head of Ventures
Trill Impact
Beth Rogozinski
Oncoustics
Jenny Rooke
Genoa Ventures
Rafael Rosengarten
Genialis Inc., USA
Alexis Rovner
64x Bio
Peter Rubin
Executive Director
No Patient Left Behind
Ed Saltzman
Senior Strategic Advisor
Lumanity
Regina Salvat
Principal
Joel Sandler
Michael Sarshad
Managing Director, Commercial Advisory Group
Syneos Health
Celestine Schnugg
Boom Capital Management
Bruce Seeley
Owner
BioOncology Consulting
Sapan Shah
Glyscend Therapeutics
Tracy Shapiro
Wilson Sonsini
Nigel Sheail
Versant Ventures
Yoshitsugu Shitaka
Astellas
Joe Shonkwiler
COO
Advanced Research Projects Agency for Health (ARPA-H)
Paul Stoffels
CEO & Chairman
Galapagos
David Suendermann-Oeft
Modality.AI, Inc.
Tari Suprapto
Director, Search and Evaluation
Kurt Thorn
Chief Technology Officer
ArrePath
Issei Tsukamoto
Global Head of Business Development
Brent Vaughan
Jane Williams
Vice President, Head of Neuroscience, Rare Disease and Pediatrics
Mylene Yao
Univfy
Eva Yin
Hanadie Yousef
Juvena Therapeutics
Ashley Zehnder
Founder and CEO
Fauna Bio